CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
about
Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytesSiglecs in the immune systemCryptic sialic acid binding lectins on human blood leukocytes can be unmasked by sialidase treatment or cellular activationTranscriptional programs of lymphoid tissue capillary and high endothelium reveal control mechanisms for lymphocyte homingCD22: an inhibitory enigmaDecoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivoAlpha2,6-sialic acid on platelet endothelial cell adhesion molecule (PECAM) regulates its homophilic interactions and downstream antiapoptotic signaling.Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acidsNew functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs.Interaction of platelet endothelial cell adhesion molecule (PECAM) with α2,6-sialylated glycan regulates its cell surface residency and anti-apoptotic role.A single N-linked glycosylation site is implicated in the regulation of ligand recognition by the I-type lectins CD22 and CD33.Alteration of the serum N-glycome of mice locally exposed to high doses of ionizing radiation.Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin GNEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does notIdentification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells.Immune regulation by the ST6Gal sialyltransferase.Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes.Sialic acids and autoimmune disease.CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.NEU1 sialidase regulates the sialylation state of CD31 and disrupts CD31-driven capillary-like tube formation in human lung microvascular endothelia.Sweet role of platelet endothelial cell adhesion molecule in understanding angiogenesis.Characterization of sialyloligosaccharide binding by recombinant soluble and native cell-associated CD22. Evidence for a minimal structural recognition motif and the potential importance of multisite binding.Sialoside specificity of the siglec family assessed using novel multivalent probes: identification of potent inhibitors of myelin-associated glycoprotein.Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells.Viewing Siglecs through the lens of tumor immunology.Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2.The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells.New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins.Loss of N-glycolylneuraminic acid in human evolution. Implications for sialic acid recognition by siglecs.Tumor necrosis factor-alpha up-regulates the expression of beta1,4-galactosyltransferase I in primary human endothelial cells by mRNA stabilization.Gene expression in thyroid autonomous adenomas provides insight into their physiopathology.Activation of human endothelial cells by tumor necrosis factor-α results in profound changes in the expression of glycosylation-related genes
P2860
Q22010812-74B56BDE-17A6-442C-B651-3A6D8AD8B74BQ24682458-D7B01022-FFD2-4DB1-84E3-B7935DC66119Q28146065-49859447-6632-4579-9ED7-80DA680BC979Q28247010-BEAC8DD1-EA47-4738-8D0C-6DA97114D0D7Q28260435-CB67E180-6AB2-4FE7-9721-08A39309D97EQ33615157-324E41BE-5BE4-4B2B-A141-6DDAC70B46BFQ33673746-873582BC-8703-4D37-9EF5-AD0A20E19CF6Q33783937-88EB00D5-85D5-435D-9CC5-576B3A7F7C52Q34184901-EC19EE0B-9549-4C97-8657-A6D7D51DE3CFQ34283441-48C68CDA-83EE-49DE-8F4D-DD24B48DFD0DQ34388465-659E744F-60C4-4FE9-B0CE-9759FC17E2FEQ34475210-EAA4B74D-20AE-44D9-AD0A-14265D544C55Q35063963-10BE2CAD-FF25-40BA-B137-115417E7F3A5Q35939859-AF174CAC-EB16-46E9-8926-0809B8918493Q36368171-D380EBBD-B942-4562-83D0-91712F4552C4Q36475650-D1619491-9923-4BD4-A595-0F327EAF7589Q36491551-89E681F3-CCBC-435B-9D37-98F753F9480DQ36625410-8C31E36D-4C79-4872-9902-0791987038C3Q37548642-D1F6DB9C-818C-46D8-AEBC-C1F926CD1CD6Q37691653-D4FF1B4B-D00C-4B07-B746-F30EDCFE7DA0Q38248549-88451E90-70D2-4342-A28A-65A4817D54E7Q38297307-DA0909F0-2045-430C-A425-2D3C43DA1B0AQ38354163-CAC520E6-3EDE-4ED5-AEB5-281823ACCCB1Q38931196-9FA2DE17-0F33-4BB5-AB8D-B25817901104Q39160967-A25C929C-E658-4B9F-B495-0FA6FFCF6C95Q40087698-4DADC1FF-D604-48F9-BB42-B98EB126DB3DQ40734041-AC24E511-5906-4D7E-8F6B-0E8F54D5F8F2Q41190891-BC3A5A08-98C4-486C-9BE8-1F0CBF206F43Q41725563-072A8A40-3145-44EA-A2F2-BF12E52D4D21Q41725570-99268374-4037-40B3-B38F-1C625E7F99BBQ45236643-1DFF9F96-47F2-4D49-8C75-0A515D7978A8Q54653332-0F9EE6E3-A248-4292-A237-4EE1FF94E156Q57261985-BE068476-4ABA-4240-A8C9-2D035A6CBB3B
P2860
CD22-mediated cell adhesion to cytokine-activated human endothelial cells. Positive and negative regulation by alpha 2-6-sialylation of cellular glycoproteins.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
CD22-mediated cell adhesion to ...... ion of cellular glycoproteins.
@en
type
label
CD22-mediated cell adhesion to ...... ion of cellular glycoproteins.
@en
prefLabel
CD22-mediated cell adhesion to ...... ion of cellular glycoproteins.
@en
P2093
P2860
P356
P1476
CD22-mediated cell adhesion to ...... ion of cellular glycoproteins.
@en
P2093
P2860
P304
P356
10.1074/JBC.270.13.7533
P407
P577
1995-03-01T00:00:00Z